[Treatment of hepatitis E virus infection].

Authors :: Kamar N
Rostaing L
Alric L
Peron JM
Izopet J
Source :: Presse medicale (Paris, France : 1983) [Presse Med] 2015 Mar; Vol. 44 (3), pp. 339-42. Date of Electronic Publication: 2015 Jan 29.
Publication Year :: 2015
Abstract: The reduction of immunosuppressive therapy is the first-line therapeutic option in transplant-patients with chronic hepatitis E virus infection. Pegylated-interferon has been used for treating hepatitis E virus infection. Ribavirin alone is the treatment of choice of hepatitis E virus infection. Ribavirin is efficient for treating chronic hepatitis E in transplant patients, HIV patients, and hematology patients receiving or not chemotherapy. Ribavirin should be given to patients presenting hepatitis E virus associated extra-hepatic manifestations. The place of ribavirin therapy at acute phase is yet to be determined.<br /> (Copyright © 2015 Elsevier Masson SAS. All rights reserved.)